You might find this interesting reading
http://mdxhealth.com/press-release/m...lished-journal
PS-Learned some very valuable lessons reading the DIL thread from start to finish some time back--developed an exit strategy and used it with my 2 ventures into PEB---cut my losses the first time--exited with overall profit the second time.
Realized that regardless of the many varying FA opinions that its better to wait till they actually prove them selves with actual results and start an uptrend and jump on at that point losing initial profits but less chance of suffering losses (a small to medium profit is better than gambling a big loss against a larger profit)
Would like to see a kiwi company do well ,but not going to finance the fact that they may not--Have no illusions that the US market is not a very large complicated beast and is a level playing field.
Have owned other biotecs that have had the backing of big names and learned the importance of that.
Watch with interest......Guess thats category 13:)